Further, cell surface expression of TLR3 has been reported in a variety of cells such as pulmonary cells, hepatocytes, breast cancer, prostate cancer, and epithelial adenocarcinoma (4–6) indicating that its signaling occurs through the plasma membrane. The gene discussed is TLR3; the disease is prostate carcinoma.